Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-19358338

ABSTRACT

We applied a newly-established method in haemolymph of mussels, Mytilus galloprovincialis, exposed to different concentrations of heavy metals, such as zinc and cadmium and organic pollutants, such as PAHs and lindane, for the detection of total antioxidant capacity (TAC). The susceptibility of exposed mussels was increased in relation to oxidative stress induced by contaminants tested. Oxidative modifications of proteins were estimated by measuring protein carbonyl content (PCC) and malondialdehyde levels (MDA). For PCC measurement, a highly sensitive and accurate ELISA method, which requires only 5 microg of protein, was used. The significant increase of PCC and MDA in haemolymph of exposed mussels reinforces its role as biomarkers of oxidative stress. Significant correlation of TAC assay, PCC and MDA was conducted in order to evaluate the utility of PCC and TAC assay, used in the present study, as tools for determining oxidative effects of pollutants in mussels. The results reinforce the application of PCC method as useful tool for the determination of PCC alterations in haemolymph of mussels exposed to different levels of contaminants. In addition, the TAC method gives encouraging results, concerning its ability to predict antioxidant efficiency in haemolymph of mussels exposed to inorganic and organic contaminants.


Subject(s)
Biomarkers/analysis , Hemolymph/drug effects , Mytilus/drug effects , Oxidants/pharmacology , Water Pollutants, Chemical/pharmacology , Acetone/toxicity , Animals , Antioxidants/analysis , Cadmium/toxicity , Environmental Monitoring , Hexachlorocyclohexane/toxicity , Malondialdehyde/analysis , Oxidation-Reduction , Oxidative Stress , Polycyclic Aromatic Hydrocarbons/toxicity , Protein Carbonylation/drug effects , Zinc/toxicity
2.
Cytotherapy ; 9(7): 654-9, 2007.
Article in English | MEDLINE | ID: mdl-17917886

ABSTRACT

BACKGROUND: For the application of umbilical cord blood (UCB) units as hematopoietic grafts, a dose of 3.7 x 10(7) nucleated cells (NC)/kg body weight is required. NC can be lost during volume-reduction processing and during thawing. A novel modification of the double-processing protocol with the aim of minimizing NC loss is described and evaluated. METHODS: One-hundred and fifty UCB were collected. The volume was reduced by a centrifugation step following double-processing in the presence of 2% HES 200/0.5. Pre- and post-processing cell counts and platelet parameters were measured with an automatic counter. The number of viable CD34+ hemopoietic stem cells was measured by flow cytometry. In 25 of the samples, colony-forming units (CFU) were also determined. The same samples were thawed 6 months after cryopreservation and re-evaluated. RESULTS: The volume was reduced to 6 +/- 1.5 mL. The recovery of NC, MNC, CD34+ hemopoietic stem cells, RBC depletion and CFU following double-processing was 93.6 +/- 3.2%, 95.8 +/- 2.2%, 98.4 +/- 1.5%, 96.8 +/- 1.1% and 107.1 +/- 6.1% (for 25 samples), respectively. The post-thaw recoveries of NC, MNC, CD34+ hemopoietic stem cells and CFU (for 25 samples) were 78.6 +/- 5.4%, 90.8 +/- 4.4%, 96.4 +/- 2.5%, 89.1 +/- 4.1%, respectively. No post-thaw cell aggregation was observed. A significant (P<0.05) post-thaw loss of platelets and signs of platelet activation was observed. DISCUSSION: The protocol uses non-expensive equipment and clinically approved materials and results in samples that can be used in patients with a mean weight of 32.7 kg.


Subject(s)
Blood Preservation/methods , Cryopreservation/methods , Fetal Blood/cytology , Antigens, CD34 , Blood Platelets/cytology , Cell Survival , Colony-Forming Units Assay , Cryoprotective Agents , Hematopoietic Stem Cells/cytology , Humans , Infant, Newborn
3.
Dis Colon Rectum ; 50(6): 899-907, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17353975

ABSTRACT

PURPOSE: This experimental study was designed to investigate whether iloprost can reverse impaired colonic healing caused by immediate postoperative intraperitoneal administration of 5-fluorouracil plus leucovorin. METHODS: Eighty Wistar rats were randomized into four groups. After resection of a 1-cm segment of transverse colon, an end-to-end sutured anastomosis was generated. Rats received saline solution (Group 1), 5-fluorouracil plus leucovorin (Group 2), iloprost (Group 3), and 5-fluorouracil plus leucovorin plus iloprost (Group 4) intraperitoneally from the day of operation and once daily until killing. Each group was further randomized into two subgroups. Subjects were killed on the fifth (Subgroup a) and eighth (Subgroup b) postoperative days. After killing, anastomoses were examined macroscopically and graded histologically. Rats were measured for anastomotic bursting pressures and tissue hydroxyproline levels. RESULTS: The leakage rate of the anastomoses was significantly higher in the 5-fluorouracil plus leucovorin group compared with the other groups (P = 0.049). Bursting pressure was significantly lower in 2a subgroup (5-fluorouracil plus leucovorin, postoperative Day 5) than in 4a (5-fluorouracil plus leucovorin plus iloprost, postoperative Day 5; P < 0.001). Adhesion formation was significantly higher in all b subgroups compared with the Control b subgroup. Neoangiogenesis was significantly higher in iloprost and iloprost plus 5-fluorouracil plus leucovorin subgroups compared with the 5-fluorouracil plus leucovorin subgroups. Hydroxyproline levels, collagen deposition, fibroblasts, and white cell count were significantly higher in the iloprost plus 5-fluorouracil plus leucovorin b subgroup (postoperative Day 8) compared with the 5-fluorouracil plus leucovorin b subgroup (postoperative Day 8). CONCLUSIONS: The immediate postoperative, intraperitoneal administration of iloprost counteracts and reverses the negative effects of 5-fluorouracil plus leucovorin chemotherapy and protects colonic healing in rats.


Subject(s)
Colon/surgery , Iloprost/pharmacology , Postoperative Complications/drug therapy , Vasodilator Agents/pharmacology , Wound Healing/drug effects , Anastomosis, Surgical/adverse effects , Animals , Antimetabolites, Antineoplastic/administration & dosage , Antimetabolites, Antineoplastic/adverse effects , Collagen/drug effects , Collagen/metabolism , Colon/metabolism , Female , Fibroblasts/drug effects , Fibroblasts/metabolism , Fluorouracil/administration & dosage , Fluorouracil/adverse effects , Hydroxyproline/metabolism , Injections, Intraperitoneal , Leucovorin/administration & dosage , Leucovorin/adverse effects , Manometry , Models, Animal , Neovascularization, Physiologic/drug effects , Postoperative Complications/chemically induced , Random Allocation , Rats , Rats, Wistar , Tissue Adhesions/chemically induced , Tissue Adhesions/prevention & control , Vitamin B Complex/administration & dosage , Vitamin B Complex/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...